Nelson Ferreira

2.2k total citations · 1 hit paper
31 papers, 1.7k citations indexed

About

Nelson Ferreira is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Nelson Ferreira has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Neurology and 12 papers in Physiology. Recurrent topics in Nelson Ferreira's work include Parkinson's Disease Mechanisms and Treatments (14 papers), Alzheimer's disease research and treatments (11 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (11 papers). Nelson Ferreira is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (14 papers), Alzheimer's disease research and treatments (11 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (11 papers). Nelson Ferreira collaborates with scholars based in Denmark, Portugal and Germany. Nelson Ferreira's co-authors include Maria Rosário Almeida, Maria João Saraiva, Poul Henning Jensen, Nádia Pereira Gonçalves, Christian Bjerggaard Vægter, Asad Jan, Per Borghammer, Jens Randel Nyengaard, Nathalie Van Den Berge and Aage Kristian Olsen Alstrup and has published in prestigious journals such as Nature Communications, PLoS ONE and Brain.

In The Last Decade

Nelson Ferreira

31 papers receiving 1.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats

2019 227 citations Nathalie Van Den Berge, Nelson Ferreira et al. Acta Neuropathologica profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nelson Ferreira Denmark	23	858	596	554	232	228	31	1.7k
Ángeles Martín‐Requero Spain	26	780 0.9×	561 0.9×	428 0.8×	101 0.4×	146 0.6×	82	1.6k
Subir Roy Chowdhury Canada	25	944 1.1×	815 1.4×	182 0.3×	108 0.5×	158 0.7×	53	1.9k
Ju Gao China	23	1.1k 1.3×	471 0.8×	383 0.7×	82 0.4×	125 0.5×	71	2.1k
Saurav Brahmachari United States	20	669 0.8×	349 0.6×	628 1.1×	91 0.4×	96 0.4×	23	1.8k
Marilena D’Aurelio United States	21	1.8k 2.1×	425 0.7×	481 0.9×	63 0.3×	147 0.6×	31	2.6k
Michaeline Hebron United States	25	847 1.0×	837 1.4×	886 1.6×	134 0.6×	188 0.8×	47	2.5k
Jianhua Shi China	24	1.3k 1.5×	775 1.3×	196 0.4×	72 0.3×	222 1.0×	49	2.1k
Xiaopin Ma United States	14	1.4k 1.6×	697 1.2×	355 0.6×	55 0.2×	149 0.7×	18	2.2k
Tomohiro Chiba Japan	24	784 0.9×	633 1.1×	119 0.2×	145 0.6×	74 0.3×	64	1.8k
Kaifu Ke China	22	628 0.7×	248 0.4×	257 0.5×	58 0.3×	93 0.4×	72	1.3k

Countries citing papers authored by Nelson Ferreira

Since Specialization

Citations

This map shows the geographic impact of Nelson Ferreira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nelson Ferreira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nelson Ferreira more than expected).

Fields of papers citing papers by Nelson Ferreira

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nelson Ferreira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nelson Ferreira. The network helps show where Nelson Ferreira may publish in the future.

Co-authorship network of co-authors of Nelson Ferreira

This figure shows the co-authorship network connecting the top 25 collaborators of Nelson Ferreira. A scholar is included among the top collaborators of Nelson Ferreira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nelson Ferreira. Nelson Ferreira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jan, Asad, Nádia Pereira Gonçalves, Christian Bjerggaard Vægter, Poul Henning Jensen, & Nelson Ferreira. (2021). The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses. International Journal of Molecular Sciences. 22(15). 8338–8338. 72 indexed citations

Ferreira, Nelson, Nádia Pereira Gonçalves, Asad Jan, et al.. (2021). Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain. Acta Neuropathologica Communications. 9(1). 31–31. 53 indexed citations

Berge, Nathalie Van Den, Nelson Ferreira, Trine Werenberg Mikkelsen, et al.. (2021). Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats. Brain. 144(6). 1853–1868. 91 indexed citations

Delaidelli, Alberto, Mette Richner, Lixiang Jiang, et al.. (2021). α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response. Acta Neuropathologica Communications. 9(1). 105–105. 30 indexed citations

Jensen, Nanna Møller, Nelson Ferreira, Sissel Ida Schmidt, et al.. (2021). Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein. PLoS ONE. 16(10). e0252635–e0252635. 22 indexed citations

Jensen, Nanna Møller, Nelson Ferreira, Cristine Betzer, et al.. (2019). Organotypic slice culture model demonstrates inter-neuronal spreading of alpha-synuclein aggregates. Acta Neuropathologica Communications. 7(1). 213–213. 44 indexed citations

Berge, Nathalie Van Den, Nelson Ferreira, Hjalte Gram, et al.. (2019). Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Acta Neuropathologica. 138(4). 535–550. 227 indexed citations breakdown →

Richner, Mette, et al.. (2019). Functional and Structural Changes of the Blood-Nerve-Barrier in Diabetic Neuropathy. Frontiers in Neuroscience. 12. 1038–1038. 93 indexed citations

Jan, Asad, Alberto Delaidelli, Nelson Ferreira, et al.. (2018). Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity. Acta Neuropathologica Communications. 6(1). 54–54. 45 indexed citations

10.

Kofoed, Rikke Hahn, Jin Zheng, Nelson Ferreira, et al.. (2017). Polo-like kinase 2 modulates α-synuclein protein levels by regulating its mRNA production. Neurobiology of Disease. 106. 49–62. 17 indexed citations

11.

Ferreira, Nelson, Nádia Pereira Gonçalves, Maria João Saraiva, & Maria Rosário Almeida. (2016). Curcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis. Scientific Reports. 6(1). 26623–26623. 43 indexed citations

12.

Lassen, Louise Berkhoudt, Lasse Reimer, Nelson Ferreira, Cristine Betzer, & Poul Henning Jensen. (2016). Protein Partners of α‐Synuclein in Health and Disease. Brain Pathology. 26(3). 389–397. 35 indexed citations

13.

Sant’Anna, Ricardo, Pablo Gallego, Nelson Ferreira, et al.. (2016). Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity. Nature Communications. 7(1). 10787–10787. 144 indexed citations

14.

Ferreira, Nelson, et al.. (2015). Transthyretin chemical chaperoning by flavonoids: Structure–activity insights towards the design of potent amyloidosis inhibitors. Biochemistry and Biophysics Reports. 3. 123–133. 22 indexed citations

15.

Ferreira, Nelson, Aida Attar, Frank‐Gerrit Klärner, et al.. (2014). Molecular Tweezers Targeting Transthyretin Amyloidosis. Neurotherapeutics. 11(2). 450–461. 38 indexed citations

16.

Ferreira, Nelson, Maria João Saraiva, & Maria Rosário Almeida. (2012). Epigallocatechin-3-Gallate as a Potential Therapeutic Drug for TTR-Related Amyloidosis: “In Vivo” Evidence from FAP Mice Models. PLoS ONE. 7(1). e29933–e29933. 96 indexed citations

17.

Ferreira, Nelson, Sónia A.O. Santos, M. Rosário Domingues, Maria João Saraiva, & Maria Rosário Almeida. (2012). Dietary curcumin counteracts extracellular transthyretin deposition: Insights on the mechanism of amyloid inhibition. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1832(1). 39–45. 42 indexed citations

18.

Ferreira, Nelson, Maria João Saraiva, & Maria Rosário Almeida. (2011). Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation. FEBS Letters. 585(15). 2424–2430. 136 indexed citations

19.

Ferreira, Nelson, Isabel Cardoso, M. Rosário Domingues, et al.. (2009). Binding of epigallocatechin‐3‐gallate to transthyretin modulates its amyloidogenicity. FEBS Letters. 583(22). 3569–3576. 125 indexed citations

20.

Macedo, Bárbara, Ana Rita Batista, Nelson Ferreira, Maria Rosário Almeida, & Maria João Saraiva. (2008). Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of Familial Amyloidotic Polyneuropathy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1782(9). 517–522. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact